Home/Rapport Therapeutics/Abraham (Avri) C. C. C. C. C.
A(

Abraham (Avri) C. C. C. C. C.

Chief Executive Officer & Director

Rapport Therapeutics

Rapport Therapeutics Pipeline

DrugIndicationPhase
RAP-219Drug-Resistant Focal EpilepsyPhase 1b/2a
Undisclosed GABA-A RAP ProgramAnxiety DisordersDiscovery
Undisclosed AMPA RAP ProgramCognitive ImpairmentDiscovery